A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis
Clinical trial NCT05372653 · COMPLETED
Trial details
- NCT number
- NCT05372653
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2022-12-29
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.